
Psychemedics Corporation PMD
Quarterly report 2024-Q3
added 11-12-2024
Psychemedics Corporation DSO Ratio 2011-2026 | PMD
Annual DSO Ratio Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.3 | 56.8 | 54.7 | 61 | 36.6 | 41.3 | 41.3 | 54.7 | 59.3 | 73.7 | 66.9 | 79.2 | 76.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.2 | 36.6 | 58.7 |
Quarterly DSO Ratio Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.3 | 67 | 64.5 | - | 68.8 | 66.4 | 60.7 | - | 65.5 | 63.8 | 61.8 | - | 59.2 | 59.9 | 58.9 | 57.4 | 59.2 | 92.4 | 43.2 | 39.6 | 35 | 37.1 | 40 | 44.4 | 40 | 40.9 | 38.9 | 42 | 40.8 | 42.3 | 46.1 | - | - | - | - | - | - | - | - | 55 | 48.3 | 48.4 | 54.7 | 61.5 | 56.5 | 57.8 | 63.8 | 74.5 | 65.3 | 61.5 | 66.6 | 73.9 | 64.9 | 65.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.4 | 35 | 56.1 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.95 | -1.97 % | $ 957 M | ||
|
Agilent Technologies
A
|
63.8 | $ 115.26 | -0.19 % | $ 35 B | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 166.68 | -4.15 % | $ 8.26 B | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 25.08 | 0.95 % | $ 697 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Danaher Corporation
DHR
|
55.3 | $ 191.97 | 0.44 % | $ 137 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
DexCom
DXCM
|
87 | $ 62.95 | 1.17 % | $ 24.6 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.54 | -1.66 % | $ 500 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
46.1 | $ 90.17 | -3.9 % | $ 11.3 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.03 | -1.06 % | $ 173 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 110.02 | -3.65 % | $ 9.07 B | ||
|
Illumina
ILMN
|
61.3 | $ 127.46 | 0.06 % | $ 20.3 B | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 170.2 | -1.77 % | $ 29.3 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 274.39 | 0.24 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 76.15 | 0.07 % | $ 5.14 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 496.01 | -0.47 % | $ 14.3 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 265.73 | 0.46 % | $ 26.1 B | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.56 | -2.72 % | $ 3.59 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 7.94 | -0.73 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.46 | 0.53 % | $ 2.05 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.42 | 1.52 % | $ 390 M | ||
|
Biodesix
BDSX
|
41.7 | $ 15.96 | 5.91 % | $ 2.07 B | ||
|
Natera
NTRA
|
81.5 | $ 204.3 | -1.77 % | $ 20.1 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.42 | 5.6 % | $ 426 M | ||
|
Precipio
PRPO
|
21.1 | $ 26.25 | 3.35 % | $ 42.1 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.59 | 0.15 % | $ 390 M | ||
|
RadNet
RDNT
|
34.5 | $ 55.09 | 0.55 % | $ 4.14 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 6.81 | -1.3 % | $ 284 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Sotera Health Company
SHC
|
43.9 | $ 14.86 | -0.67 % | $ 4.22 B | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 52.3 | 32.43 % | $ 2.66 B | ||
|
Neuronetics
STIM
|
48.7 | $ 1.79 | 17.76 % | $ 118 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 485.83 | -1.15 % | $ 183 B |